Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04868903 · ClinicalTrials.gov registry record · NA
Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 1,475
- Enrollment target
NCT04868903 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 1,475 participants.
The verdict
NCT04868903, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,475 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the risks of COVID-19 in individuals from Chicagoland communities randomized to low (400 IU/day) vs. moderate (4,000 IU/day) or high (10,000 IU/day) dose vitamin D.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,475 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04868903
The ClinicalTrials.gov registry entry for NCT04868903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,475 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT04868903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04868903 about?
NCT04868903 is a clinical study titled "Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19". The purpose of this study is to compare the risks of COVID-19 in individuals from Chicagoland communities randomized to low (400 IU/day) vs. moderate (4,000 IU/day) or high (10,000 IU/day) dose vitamin D.
What is the current status of trial NCT04868903?
This trial is currently completed. It is a NA study. The enrollment target is 1,475 participants. The study started on 2020-11-30. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT04868903?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04868903?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.